Structure of human V-ATPase with the a2-isoform reveals a proton-release gate in the luminal half-channel
This study utilizes cryo-EM to reveal the structure of human V-ATPase with the a2-isoform, identifying a conserved salt bridge in the luminal half-channel that acts as a proton-release gate to regulate pump activity in higher eukaryotes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside nearly every cell of the human body, tiny molecular machines work tirelessly to maintain the delicate balance of acidity required for life. These machines, known as V-ATPases, act as pumps that move protons—positively charged hydrogen atoms—from the watery interior of the cell into the enclosed compartments where biological processes happen. By pumping these protons, the machine acidifies these compartments, creating the specific chemical environment needed for digestion, signaling, and the transport of materials. Without this precise control, cells cannot function, and in mammals, the complete loss of this activity is fatal. While these pumps are essential, they are also complex, and their behavior changes depending on where they are located and which specific version of their parts they contain.
Scientists have long known that the human version of this pump has different variations, or isoforms, of a key component called the a-subunit. One of these versions, the a2-isoform, is particularly important because it resides in the Golgi apparatus and early endosomes, the cell's sorting and packaging centers. Mutations in the gene that creates this specific a2-part are linked to serious human conditions, including a rare skin disorder called cutis laxa, where the skin loses its elasticity, as well as issues with male fertility and certain cancers. Despite knowing that this specific version is vital for health, researchers did not have a clear picture of its three-dimensional structure or how it might differ from other versions to perform its unique duties.
To fill this gap, a team of researchers at Stony Brook University turned to a powerful imaging technique called cryo-electron microscopy. This method allows scientists to flash-freeze individual molecules in a thin layer of ice and capture thousands of images from different angles, which are then combined to build a detailed 3D model. The team focused on isolating the human V-ATPase containing the a2-isoform from human cells. They successfully captured the machine in two different states: first, as a fully assembled, working unit, and second, as a disassembled subunit where the motor part had detached from the membrane-embedded pump. By comparing these structures, they hoped to understand why the a2 version behaves differently than other human versions and how its unique shape relates to the diseases caused by its malfunction.
The researchers found that the human V-ATPase with the a2-isoform is inherently less stable than the version containing the a4-isoform. When they purified the proteins in the lab, the a2-containing machine fell apart much more easily, separating into its two main components. This observation suggests that the a2 version is naturally designed to be more flexible and easier to disassemble, which aligns with its role in cellular compartments that require rapid changes in acidity. The study also revealed a unique structural feature on the a2-isoform: a long loop of protein that extends into the empty space inside the cell compartment, a feature not found in other human versions. This loop contains a cluster of histidine amino acids, which the researchers believe act as sensors to detect the pH level of the environment, helping the cell decide when to activate or deactivate the pump.
Perhaps the most striking discovery was a molecular "gate" that controls the flow of protons. In the structure of the a2-isoform, the team observed a salt bridge—a strong electrical attraction between two oppositely charged parts of the protein—that blocks the channel through which protons must travel to exit the pump. This blockage is not present in the yeast version of the pump, which is simpler and lacks this regulatory feature. The researchers used computer simulations to watch how this gate behaves over time. The simulations showed that the salt bridge is not permanent; it breaks and reforms, suggesting that the gate opens and closes to regulate the flow of protons. This mechanism likely explains why human V-ATPases are more tightly controlled than their yeast counterparts, preventing them from pumping protons when it is not necessary.
The study also mapped the locations of specific genetic mutations found in patients with cutis laxa onto the 3D model. The researchers saw that many of these disease-causing errors occur right along the path where protons travel or in regions that stabilize the pump's structure. For instance, some mutations affect the very gate that controls proton flow, while others disrupt the unique loop that senses pH. By seeing exactly where these errors sit in the machine, the scientists can now hypothesize how they break the pump's function, leading to the glycosylation defects and trafficking problems that cause the disease symptoms. This structural insight provides a concrete foundation for understanding how a single change in a protein's shape can lead to widespread cellular failure.
Ultimately, this work transforms our understanding of how human cells regulate their internal acidity. It reveals that the human V-ATPase is not just a simple pump but a sophisticated machine with built-in safety gates and sensors that are unique to higher organisms. The discovery of the salt bridge gate offers a new explanation for how these pumps are regulated in humans, distinguishing them from the simpler versions found in yeast. By visualizing the exact positions of disease-causing mutations, the study opens the door to more targeted approaches for understanding and potentially treating the conditions associated with V-ATPase malfunctions. The research confirms that the a2-isoform is a specialized, finely tuned component of the cell, designed to be both responsive to its environment and vulnerable to specific errors that can have profound consequences for human health.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.